HER-2 Expression in Breast Cancer Cells and Its Effect on Anti-Apoptotic Proteins
Author Information
Author(s): Siddiqa Aisha, Long Linda M, Li Liuxia, Marciniak Robert A, Kazhdan Irene
Primary Institution: University of Texas Health Science Center, San Antonio, TX, USA
Hypothesis
The study investigates how HER-2 overexpression affects apoptotic pathways in MCF-7 breast cancer cells.
Conclusion
Short term overexpression of HER-2 increases levels of antiapoptotic proteins Bcl-2 and survivin in MCF7 cells through ERK and PI3K signaling pathways.
Supporting Evidence
- HER-2 is over-expressed in 20-30% of breast cancers, leading to poor prognosis.
- The study found that HER-2 overexpression increased survivin and Bcl-2 levels.
- ERK and PI3K pathways were identified as key signaling pathways for survivin up-regulation.
Takeaway
When breast cancer cells have more HER-2, they can survive better because they make more proteins that help them avoid dying.
Methodology
The study used tetracycline-regulated HER-2 expression in MCF-7 cells to examine the modulation of apoptotic pathways over 48 hours.
Limitations
The study focused on short-term effects of HER-2 overexpression, which may not reflect long-term outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website